Medical Device Network on MSN
Cognito Therapeutics raises $105M for Alzheimer’s therapeutic advancement
With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s disease therapeutic in the US by 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results